(A) Self-reported ancestry of the 13 probands.
(B) Proportion of probands with suspected pathogenic variants in the indicated genes.
(C) Pedigrees grouped by affected gene. Asterisks indicate previously reported pedigrees.
(D) Schematic of loci and variants identified.
(E) Protein schematics with variants identified. C, cytoplasmic domain; TM, transmembrane domain; CUB, Complement C1r/C1s, Uegf, Bmp1 domain; L, LDL-receptor class A domain; FZ, frizzled domain; CC, coiled-coil domain.